15 insiders have filed at ARWR since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Anzalone Christopher Richard | Chief Executive Officer | 3.79M | 2.663% | 46 sells $37.4M | |
| O'Brien Patrick | COO | 547.4k | 0.384% | 23 sells $5.0M | |
| Myszkowski Kenneth Allen | Chief Financial Officer | 455.4k | 0.32% | 8 sells $2.9M | |
| Hamilton James C | Chief Medical Officer | 237.0k | 0.166% | 26 sells $7.5M | |
| San Martin Javier | Chief Medical Officer | 198.5k | 0.139% | 5 sells $860k | |
| Apel Daniel Joseph | Chief Financial Officer | 176.2k | 0.124% | ||
| Oliver Tracie | Chief Commercial Officer | 127.1k | 0.089% | 3 sells $555k | |
| Given Douglas B | Director | 124.2k | 0.087% | 4 sells $232k | |
| Perry Michael S | Director | 123.1k | 0.086% | 1 sells $992k | |
| Ferrari Mauro | Director | 69.1k | 0.048% | 4 sells $1.1M | |
| Waddill William D. | Director | 56.6k | 0.04% | 7 sells $880k | |
| Lu Hongbo | Director | 55.0k | 0.039% | 8 buys $145k | |
| Ingram Douglas S | Director | 46.2k | 0.032% | ||
| Vakiener Victoria | Director | 35.7k | 0.025% | 8 sells $1.1M | |
| Olukotun Adeoye Y | Director | 33.6k | 0.024% | 5 sells $754k |
Full register at boothcheck.com/insiders/ARWR. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.